From the previous experience:
The FDA and the EMA go their separate ways on DMD: CHMP slaps down Sarepta but offers rival PTC an expanded market
https://endpts.com/the-fda-and-the-ema-go-their-separate-ways-on-dmd-chmp-slaps-down-sarepta-but-offers-rival-ptc-an-expanded-market/
"European and US regulators occasionally take completely conflicting stands on drugs, and nowhere is that more evident than in Duchenne muscular dystrophy."
"...there are plenty of industry execs who believe that neither drug should be on the market with the data that’s been available so far. But they don’t get a vote."
YES! I think both FDA and EMA should work hand in hand for any drugs development including DMD!!
- Forums
- ASX - By Stock
- US deal for ATL1102
From the previous experience:The FDA and the EMA go their...
-
- There are more pages in this discussion • 179 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.7¢ |
Change
0.003(3.57%) |
Mkt cap ! $78.43M |
Open | High | Low | Value | Volume |
8.4¢ | 8.7¢ | 8.4¢ | $72.99K | 855.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 452608 | 8.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.7¢ | 398595 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 452608 | 0.084 |
3 | 212500 | 0.083 |
2 | 106250 | 0.080 |
2 | 125578 | 0.079 |
1 | 12462 | 0.078 |
Price($) | Vol. | No. |
---|---|---|
0.087 | 398595 | 1 |
0.088 | 400000 | 1 |
0.089 | 135000 | 2 |
0.090 | 794374 | 5 |
0.092 | 50000 | 1 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online